Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel, Benjamin Rossi, Romain Remark, Violette Breso, Elodie Bonnet, Guillaume Habif, Sophie Guia, Ana Inés Lalanne, Caroline Hoffmann, Olivier J Lantz, Jérôme Fayette, Agnès Boyer-Chammard, Robert Albert Zerbib, Pierre F. Dodion, Hormas Ghadially, Maria Jure‐Kunkel, and 5 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.cell.2018.10.014
- Published
- Nov 29, 2018
- Venue
- Cell
- DOI
- 10.1016/j.cell.2018.10.014
- PubMed
- 30503213
- Categories
- Immune Cell Function and Interaction
- License
- cc-by-nc-nd
- Provenance
- openalex